|
|
|
Volumn 25, Issue 10, 2011, Pages 906-
|
|
FDA approves vemurafenib for treatment of metastatic melanoma.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
B RAF KINASE;
INDOLE DERIVATIVE;
SULFONAMIDE;
VEMURAFENIB;
ARTICLE;
DRUG ANTAGONISM;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
GENETICS;
HUMAN;
MELANOMA;
METASTASIS;
MUTATION;
PATHOLOGY;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
HUMANS;
INDOLES;
MELANOMA;
MUTATION;
NEOPLASM METASTASIS;
PROTO-ONCOGENE PROTEINS B-RAF;
SULFONAMIDES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 80555156569
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|